Everest Organics Ltd. lags significantly behind its peers in almost all key financial metrics, showing no revenue growth, negative PE ratio, and poor profitability indicators. This reflects a challenging operational environment and raises concerns over its financial stability compared to other companies in the Pharmaceuticals & Drugs sector.

• • Everest Organics Ltd. has zero revenue growth and negative EPS, indicating lack of profitability and growth potential.
• • Sun Pharmaceutical Industries Ltd. leads in profitability metrics with a PE of 87.59 and ROE of 16.13%.
• • Dr. Reddy's Laboratories Ltd. ranks highest in terms of profitability while being attractively valued, making it a strong contender for investment.